# PACLITAXEL
> **ANDA209657** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2025-04-10
## Drug
- **FDA Application Number:** ANDA209657
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PACLITAXEL
- **Generic name:** PACLITAXEL PROTEIN-BOUND PARTICLES
- **Active ingredients:** PACLITAXEL
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2025-04-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209657)
---
*AI Analytics · CC0 1.0*